Good news for the follicularly challenged: soon Shane Warne can part ways with Advanced Hair Studio and the Channel 9 make-up department won’t be applying Kiwi shoe polish to the noggins of Karl Stefanovic and yours truly.

Thank small-cap biotech Cellmid , which today will announce the acquisition of Japanese hair growth company Advangen. The deal gives Cellmid control of the FGF-5 inhibitor technology which underpins the company’s Evolis hair product range. Evolis is one of only two hair growth companies in Australia approved by the Therapeutic Goods Administration.